A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

PHASE3CompletedINTERVENTIONAL
Enrollment

3,682

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

November 30, 2007

Conditions
HIV InfectionsHIV SeronegativityHerpes Genitalis
Interventions
DRUG

Acyclovir

400 mg tablet taken orally twice daily

DRUG

Acyclovir placebo

Oral tablet taken twice daily

Trial Locations (3)

94102

San Francisco Department of Public Health, AIDS Office, Research Section, San Francisco

98104

University of Washington, Seattle

Unknown

New York Blood Center, New York

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00076232 - A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes | Biotech Hunter | Biotech Hunter